Naringin Protects Against High Glucose-Induced Human Endothelial Cell Injury Via Antioxidation and CX3CL1 Downregulation
Background/Aims: The induction of endothelial injury by hyperglycemia in diabetes has been widely accepted. Naringin is a bio-flavonoid. Some studies showed that naringin alleviates diabetic complications, but the exact mechanisms by which naringin improves diabetic anomalies are not yet fully under...
Main Authors: | Guilin Li, Yurong Xu, Xuan Sheng, Hua Liu, Jingjing Guo, Jiayue Wang, Qi Zhong, Huaide Jiang, Chaoran Zheng, Mengxia Tan, Shenqiang Rao, Yanling Yu, Yun Gao, Guodong Li, Shangdong Liang, Gaochun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-08-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/480215 |
Similar Items
-
Differential angiogenic activities of naringin and naringenin in zebrafish in vivo and human umbilical vein endothelial cells in vitro
by: Linmin Chen, et al.
Published: (2018-10-01) -
Effects of Naringin on Cardiomyocytes From a Rodent Model of Type 2 Diabetes
by: A. Uryash, et al.
Published: (2021-08-01) -
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
by: Cristina eLimatola, et al.
Published: (2014-08-01) -
Studies on the interaction of naringin palmitate with lysozyme by spectroscopic analysis
by: Xia Zhang, et al.
Published: (2014-05-01) -
Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)